Physician profile
Cherie P Wright
NPI 1760499040
$1,292.04
in general payments reported to CMS, 2019-2025
8 companies · $617 in 2025
The $617 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $173 · 2023: $276 · 2024: $226 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $298.64 | 2022-2025 | Wegovy |
| Astrazeneca Pharmaceuticals Lp | $231.85 | 2024-2025 | Breztri, Farxiga |
| Abbvie INC. | $229.68 | 2022-2025 | |
| Vifor Pharma, INC. | $125.00 | 2025 | Veltassa |
| Paratek Pharmaceuticals, INC. | $125.00 | 2023 | Nuzyra |
| Lilly USA, LLC | $123.27 | 2025 | Mounjaro |
| Janssen Pharmaceuticals, INC | $119.48 | 2024 | Xarelto |
| Myriad Genetic Laboratories, INC. | $39.12 | 2023 | Colaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cherie Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.